Showing
1 - 2
results of
2
for search '
Ayers, D.
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Ayers, D.
Showing
1 - 2
results of
2
for search '
Ayers, D.
'
, query time: 0.05s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma
by
Ayers
,
D
.
,
Cope, S.
,
Davies, F.E
,
Dhanasiri, S.
,
Dhanda, D.
,
Hari, P.
,
Hege, K.
,
Mojebi, A.
,
Patel, P.
,
Shah, N.
Published 2022
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
2
Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma
by
Atsou, K.
,
Ayers
,
D
.
,
Chen, C.-I
,
Cope, S.
,
Guyot, P.
,
Keeping, S.
,
Konidaris, G.
,
Kuznik, A.
,
Mojebi, A.
,
Paul, E.
,
Sasane, M.
,
Xu, Y.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Humans
Progression-Free Survival
human
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Article
CAR T cell therapy
Carcinoma, Squamous Cell
Cost-Benefit Analysis
Multiple Myeloma
Receptors, Chimeric Antigen
United States
Willingness To Pay
adult
advanced cancer
antineoplastic agent
cancer chemotherapy
cancer growth
cancer survival
cemiplimab
controlled study
conventional care
cost benefit analysis
cost effectiveness analysis
drug cost
drug therapy
economics
excision
Loading...